Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease

Shown as published in the source's RSS feed — the text above is everything the feed itself carried. Follow the source link for the complete article on the publisher's own site; it opens in a new tab.